Theranostic Photosensitive Nanoparticles for Lymph Node Metastasis of Gastric Cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25986868.
- Also identified by DOI 10.1245/s10434-015-4594-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preoperative and intraoperative diagnoses of lymph node (LN) metastasis in patients with gastric cancer is essential to determine the extent of LN dissection in order to establish individualized treatment strategies. We investigated the theranostic value of a newly developed drug delivery system employing nanoparticles loaded with the indocyanine green (ICG) derivative ICG-loaded lactosome (ICGm) using a murine draining LN metastasis model of gastric cancer. In the experimental draining LN metastasis model of human gastric cancer, the right hind footpads of nude mice were injected with cancer cells. Three weeks later, either ICGm or ICG solution was injected through the tail vein. Forty-eight hours after the administration of a photosensitizer, in vivo and ex vivo imaging and photodynamic therapy (PDT) were performed, and size of the LNs was measured. In vivo imaging revealed metastatic LNs in the ICGm-treated mice but not in the ICG-treated mice. PDT using ICGm induced apoptosis and significantly inhibited the growth of metastatic LNs. ICGm presents a novel theranostic nanodevice for LN metastasis of gastric cancer.
Medical subject headings
- Adenocarcinoma
- Apoptosis
- Lymph Nodes
- Nanoparticles
- Photochemotherapy
- Photosensitizing Agents
- Stomach Neoplasms
- Theranostic Nanomedicine